Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia

Br J Anaesth. 2021 Feb;126(2):e72-e75. doi: 10.1016/j.bja.2020.11.006. Epub 2020 Nov 14.

¹ Adult Intensive Care Unit, Royal Brompton Hospital, London, UK; National Heart and Lung Institute, Imperial College London, London, UK.
² Adult Intensive Care Unit, Royal Brompton Hospital, London, UK.
³ Adult Intensive Care Unit, Harefield Hospital, Harefield, UK.
⁴ National Heart and Lung Institute, Imperial College London, London, UK; National Pulmonary Hypertension Service, Royal Brompton Hospital, UK.
⁵ Adult Intensive Care Unit, Royal Brompton Hospital, London, UK; Anaesthetics, Pain Medicine and Intensive Care, Surgery and Cancer, Imperial College London, UK.
⁶ National Heart and Lung Institute, Imperial College London, London, UK; National Pulmonary Hypertension Service, Royal Brompton Hospital, UK. Electronic address: [email protected].

No abstract available

Keywords: ARDS; COVID-19; inhaled nitric oxide; pulmonary hypertension; right ventricular dysfunction.

Publication types